Cartalax (also spelled Kartalax or Cartalax) is a synthetic bioregulatory peptide developed in Russia, primarily associated with the work of Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. It’s part of a class of short-chain peptides (like Epitalon, Thymalin, and others) designed to target specific organs or tissues, promoting repair, regeneration, and anti-aging effects. Cartalax specifically focuses on cartilage and connective tissue.

Chemical Composition

• Structure: A tetrapeptide with the amino acid sequence Ala-Glu-Asp-Gly (AEDG).
• Molecular formula: C₁₇H₂₈N₅O₉.
• Molecular weight: ~448 Da.
• It’s typically administered as a lyophilized powder for subcutaneous injection, nasal spray, or oral capsules (though bioavailability varies by form).

Purported Mechanism of Action

Cartalax is claimed to:

1. Regulate gene expression in chondrocytes (cartilage cells) and fibroblasts, increasing synthesis of collagen types I, II, and proteoglycans.
2. Normalize metabolism in cartilage tissue, reducing inflammation and oxidative stress.
3. Stimulate tissue repair by activating telomerase and promoting stem cell differentiation in joints and connective tissues.
4. Anti-aging effects: Shortens recovery time from injuries, improves joint mobility, and may slow osteoarthritis progression.

These claims stem from Russian studies, often involving animal models or small human trials. For example:

• A 2014 study in Bulletin of Experimental Biology and Medicine showed Cartalax restored cartilage structure in aged rats.
• Clinical observations (e.g., Khavinson’s work) report benefits for osteoarthritis, rheumatoid arthritis, and post-trauma recovery.

Potential Benefits (Based on Available Research)

Dosage & Usage (Common Protocols)

• Standard cycle: 10-20 mg/day subcutaneously (or 1-2 mg nasal spray) for 10-20 days, 2-3 times/year.
• Maintenance: 1-5 mg/day orally.
• Often stacked with BPC-157 or TB-500 for enhanced repair.

Evidence Level: Mostly preclinical/animal data and anecdotal reports from peptide communities (e.g., Reddit’s r/Peptides, LongeCity). Limited Western RCTs; not FDA-approved. Russian Ministry of Health lists some peptides as “geroprotectors,” but Cartalax is sold as a research chemical or supplement in many places.

Side Effects & Safety

• Generally well-tolerated: Rare reports of mild injection-site irritation or headaches.
• Contraindications: Pregnancy, acute infections, hypersensitivity.
• Long-term data: Lacking; monitor for immunogenicity with repeated use.
• Legality: Research chemical in the US/EU (not for human consumption); available via nootropic/peptide vendors like CosmicNootropic or Peptide Sciences. Check local laws.

Where to Buy & Verification

• Reputable sources test for purity (>98% via HPLC/MS).
• Avoid cheap unverified products—risk of contaminants.

If you’re considering use, consult a healthcare provider, especially for underlying conditions. Research is promising but preliminary—more robust trials needed. For deeper dives, check PubMed for “AEDG peptide” or Khavinson’s publications. Got specifics (e.g., sourcing, stacking)? Ask!